Status:

RECRUITING

Development and Evaluation of 'My Voice': a Randomized Controlled Trial

Lead Sponsor:

Duke-NUS Graduate Medical School

Collaborating Sponsors:

Changi General Hospital

Singapore General Hospital

Conditions:

Advance Care Planning

Heart Failure

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

The study aims to develop and evaluate a web-based interactive platform (called 'My Voice') that helps to educate patients with heart failure and their caregivers about heart failure, identify their g...

Detailed Description

The research study consists of 3 phases: 1. Usability testing - to assess the usability of 'My Voice' with patients with heart failure, their caregivers and healthcare providers, 2. Pilot testing - t...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • \- The inclusion criteria for patients are
  • Age ≥ 21 years old
  • Singaporean or Permanent Resident
  • Diagnosed with heart failure
  • Symptoms classified under NYHA class II (with an ejection fraction of less than or equal to 35%), III or IV
  • Intact cognition determined through the Abbreviated Mental Test (AMT) (for pilot testing and main RCT)
  • Ability to speak and read English, Mandarin or Malay
  • Willing to complete a web intervention
  • Easily contactable via mobile phone or landline
  • Have a permanent address in Singapore for at least the next 1 year
  • Not recruited in a previous phase of the study
  • The inclusion criteria for caregivers are
  • Age ≥ 21 years old
  • Nominated as a healthcare spokesperson by the patient or the main decision maker for the patient (for intervention arm only)
  • Ability to speak and read English, Mandarin or Malay
  • Willing to complete a web intervention
  • Easily contactable via mobile phone or landline
  • Have a permanent address in Singapore for at least the next 1 year
  • Exclusion criteria for caregivers are:
  • a) domestic helper

Exclusion

    Key Trial Info

    Start Date :

    March 7 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 1 2026

    Estimated Enrollment :

    244 Patients enrolled

    Trial Details

    Trial ID

    NCT06090734

    Start Date

    March 7 2024

    End Date

    February 1 2026

    Last Update

    March 21 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Duke-NUS

    Singapore, Singapore, Singapore, 169857